guidance reaffirmed

NRG Energy missed Q1 2026 earnings at $1.48 EPS versus $1.77 expected despite 19% revenue growth to $10.256 billion, pressured by hedge losses and mild weather.

Lockheed Martin's 27% stock decline following weak Q1 earnings appears oversold; management's maintained guidance and analyst price targets $653-$700 suggest recovery potential.

Bristol Myers Squibb surges 5% after beating Q1 earnings expectations, with growth portfolio sales up 12% and full-year guidance reaffirmed.

Bristol-Myers Squibb stock jumped 4.44% after Q1 earnings beat expectations, with revenue up 3% and growth portfolio surging 12% year-over-year.

HCA Healthcare reported Q1 earnings matching expectations, but respiratory admissions fell 42% and ER visits dropped 32%, triggering a 9% stock sell-off.

Hasbro rallies 7.33% after Q1 revenue of $970-985M crushes estimates, buoyed by Magic: The Gathering strength despite cybersecurity challenges.

Winnebago Industries beat earnings expectations with 27-cent adjusted EPS, but stock fell 7.58% premarket due to declining unit volumes in towable RVs and marine segments.

Hormel beat earnings estimates but missed revenue expectations as retail segment declined 6%. Foodservice and international operations offset weakness, with company reaffirming full-year guidance.

Medtronic beat Q3 sales estimates at $9.02B with 8.7% growth, reaffirming full-year guidance. Strong cardiovascular and diabetes segments drove performance despite stock decline.